
### [MONDO:0017128](http://purl.obolibrary.org/obo/MONDO_0017128)
**Label:** genetic digestive tract tumor

**Subclasses:** [MONDO:0018653](http://purl.obolibrary.org/obo/MONDO_0018653) (Polymerase proofreading-related adenomatous polyposis), [MONDO:0008021](http://purl.obolibrary.org/obo/MONDO_0008021) (Cowden syndrome 1), [MONDO:0018630](http://purl.obolibrary.org/obo/MONDO_0018630) (hereditary nonpolyposis colon cancer), [MONDO:0016063](http://purl.obolibrary.org/obo/MONDO_0016063) (Cowden disease), [MONDO:0008279](http://purl.obolibrary.org/obo/MONDO_0008279) (familial adenomatous polyposis type 1), [MONDO:0016362](http://purl.obolibrary.org/obo/MONDO_0016362) (attenuated familial adenomatous polyposis), [MONDO:0005835](http://purl.obolibrary.org/obo/MONDO_0005835) (Lynch syndrome), [MONDO:0008280](http://purl.obolibrary.org/obo/MONDO_0008280) (Peutz-Jeghers syndrome), 

**Corr. equiv. classes:** [Orphanet:144](http://www.orpha.net/ORDO/Orphanet_144), [Orphanet:201](http://www.orpha.net/ORDO/Orphanet_201), [OMIM:158350](http://purl.obolibrary.org/obo/OMIM_158350), [OMIM:615083](http://purl.obolibrary.org/obo/OMIM_615083), [Orphanet:65285](http://www.orpha.net/ORDO/Orphanet_65285), [OMIM:614350](http://purl.obolibrary.org/obo/OMIM_614350), [OMIM:612591](http://purl.obolibrary.org/obo/OMIM_612591), [OMIM:614331](http://purl.obolibrary.org/obo/OMIM_614331), [OMIM:613244](http://purl.obolibrary.org/obo/OMIM_613244), [OMIM:615107](http://purl.obolibrary.org/obo/OMIM_615107), [OMIM:614337](http://purl.obolibrary.org/obo/OMIM_614337), [OMIM:615108](http://purl.obolibrary.org/obo/OMIM_615108), [Orphanet:2869](http://www.orpha.net/ORDO/Orphanet_2869), [OMIM:616415](http://purl.obolibrary.org/obo/OMIM_616415), [Orphanet:2969](http://www.orpha.net/ORDO/Orphanet_2969), [OMIM:615106](http://purl.obolibrary.org/obo/OMIM_615106), [OMIM:612359](http://purl.obolibrary.org/obo/OMIM_612359), [OMIM:615109](http://purl.obolibrary.org/obo/OMIM_615109), [OMIM:616858](http://purl.obolibrary.org/obo/OMIM_616858), [OMIM:609310](http://purl.obolibrary.org/obo/OMIM_609310), [Orphanet:733](http://www.orpha.net/ORDO/Orphanet_733), [OMIM:614385](http://purl.obolibrary.org/obo/OMIM_614385), [Orphanet:443909](http://www.orpha.net/ORDO/Orphanet_443909), [OMIM:175200](http://purl.obolibrary.org/obo/OMIM_175200), [OMIM:175100](http://purl.obolibrary.org/obo/OMIM_175100), [Orphanet:220460](http://www.orpha.net/ORDO/Orphanet_220460), [Orphanet:99818](http://www.orpha.net/ORDO/Orphanet_99818), [OMIM:120435](http://purl.obolibrary.org/obo/OMIM_120435), [OMIM:608456](http://purl.obolibrary.org/obo/OMIM_608456), [Orphanet:247806](http://www.orpha.net/ORDO/Orphanet_247806), [Orphanet:447877](http://www.orpha.net/ORDO/Orphanet_447877), [Orphanet:79665](http://www.orpha.net/ORDO/Orphanet_79665), 

**Class expressions from DL-Learner:**

- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 50.95%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm))) 49.01%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer))) 49.01%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma))) 47.86%
- [HP:0100013](http://purl.obolibrary.org/obo/HP_0100013) (Neoplasm of the breast) 47.25%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0100787](http://purl.obolibrary.org/obo/HP_0100787) (Prostate neoplasm))) 46.80%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0100641](http://purl.obolibrary.org/obo/HP_0100641) (Neoplasm of the adrenal cortex))) 46.80%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0100631](http://purl.obolibrary.org/obo/HP_0100631) (Neoplasm of the adrenal gland))) 46.80%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0100615](http://purl.obolibrary.org/obo/HP_0100615) (Ovarian neoplasm))) 46.80%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0012125](http://purl.obolibrary.org/obo/HP_0012125) (Prostate cancer))) 46.80%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology))) 46.80%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0010622](http://purl.obolibrary.org/obo/HP_0010622) (Neoplasm of the skeletal system))) 46.80%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0008775](http://purl.obolibrary.org/obo/HP_0008775) (Abnormality of the prostate))) 46.80%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0002669](http://purl.obolibrary.org/obo/HP_0002669) (Osteosarcoma))) 46.80%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands))) 46.80%


